SHENOUDA MAGED purchased 226.4% of their position (200K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $97.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 5/20/2025ACC: 0001213900-25-046087
+200K
Net shares
Net buyer
$97.2K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
200K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+50K
Price / share
$0.44
Trade value
$22.10K
% of position
56.6%
5/16/2025
88.33K→138.34K
Common Stock
Direct
Shares
+90K
Price / share
$0.49
Trade value
$43.69K
% of position
65.1%
5/19/2025
138.34K→228.34K
Common Stock
Direct
Shares
+60K
Price / share
$0.52
Trade value
$31.42K
% of position
26.3%
5/20/2025
228.34K→288.33K
Total
Net shares
+200K
Net value
$97.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2025 | P · Purchase | +50K | $0.44 | $22.10K | 56.6% | 88.33K | 138.34K |
| Common Stock Direct | 5/19/2025 | P · Purchase | +90K | $0.49 | $43.69K | 65.1% | 138.34K | 228.34K |
| Common Stock Direct | 5/20/2025 | P · Purchase | +60K | $0.52 | $31.42K | 26.3% | 228.34K | 288.33K |
| Total | +200K | $97.21K | ||||||
Derivative Transactions0
No derivative transactions reported